DAVA Oncology was founded in 2007 with the goal of facilitating successful cancer drug development by providing innovative solutions and services to the pharmaceutical and biotechnology industries. DAVA has three business units - DAVA Clinical Trial Acceleration Services, Oncology Meeting Innovations and ONE Oncology. These business units accelerate clinical trial research timelines through MD-to-MD focused trial education, host non-CME scientific exchange programs across more than fifteen solid tumor and hematologic malignancies and create both custom and syndicated oncology education tools, respectively.

Biotechnology

Clinical Trials

Pharmaceutical

DAVA Oncology

Vinay Jain

Peter Langford

Sharon Harner

Nitya Singh

Shinjan Kapur

Kathryn Gallaway

Anjali Bose

The Business Development team at DAVA Oncology is responsible for identifying and pursuing new business opportunities, forging strategic partnerships, and expanding the company's client base within the pharmaceutical and biotechnology industries. They work closely with potential and existing clients to understand their needs, tailor DAVA's innovative solutions and services to accelerate cancer drug development, and drive company growth.

Business Development

Medical Writing and Content Development

Business Development

About

Team members

Other teams at DAVA Oncology

Medical Writing and Content Development